课题基金 / 基金详情

Defining Optimal Care for Urinary Stone Disease in the Veterans Health Administration

Defining Optimal Care for Urinary Stone Disease in the Veterans Health Administration
退伍军人健康管理局定义泌尿系结石的最佳护理
批准号:
10229348
负责人:
John Thomas Leppert
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-10-01 至 2024-09-30

项目摘要

项目成果

John Thomas Leppert的其他基金

相似基金

相关文献

中文摘要
翻译
背景:泌尿系结石病(USD)给患者带来了重大的经济和健康负担。 美国退伍军人健康管理局(VHA)。目前在提供服务方面的障碍 对USD患者的最佳医疗保健包括缺乏循证过程措施 以及USD二级预防措施的复杂性。 意义/影响:目前关于美元最佳做法管理的指导方针主要是 基于临床原则或专家意见。相对缺乏循证指南 可能导致次优护理,并驱动护理质量的不必要的实践模式变化, USD.拟议的研究将解决以下VHA/ORD优先事项:初级保健 复杂慢性病(如复发性USD)的实践和管理以及质量 预防USD。 创新:拟议的研究将确定哪些指南推荐的策略 对USD的二级预防有效。随机临床试验尚未在 因此,我们的研究结果有望迅速扩大证据基础, 最佳的护理USD和转向临床实践范式USD向初级保健 提供者,使更多的退伍军人与USD可以得到有效的石头预防。 具体目标:我们提出以下具体目标:(1)确定预防 措施与VHA中较低的USD复发率相关; 2)评估VHA如何 供应商目前正在实施USD预防措施;以及3)确定当前 在VHA中实施有效预防USD措施的障碍。我们假设 以下:1)预防措施,如筛查原发性甲状旁腺功能亢进症,24- 小时尿检和结石相关药物的处方与更长的时间有关。 至复发性USD和/或结石事件较少的时间段; 2)初级保健提供者较少 比专科提供者更有可能实施USD预防措施;以及3)每个提供者 型面特有的障碍物,降低了石料利用率,采取了有效的防治措施。 方法:目标1将确定一个全国性的退伍军人队列, 在2010年至2016年之间,使用模拟随机临床试验的方法来确定 指南建议的措施导致发生第二次USD事件的时间延长或USD减少 事件目标2将审查接受初级保健的病人比例, 肾科和泌尿科提供者在其索引结石事件后, 提供者或多或少有可能实施每一项预防措施。目标3将进行 与VHA附属的初级保健、肾脏病学和泌尿学提供者进行的全国性调查 查明执行有效的防止核泄漏措施的障碍。 后续步骤/实施:VHA的理想定位是支持比较 进行有效性研究,以确定哪些最佳做法准则在减少 美元复发。拟议的研究将更明确地界定最佳做法管理, USD,评估VHA提供商目前如何实施预防措施,以及 找出妨碍在各部门统一采用最佳管理方法的障碍, VHA。我们预计,我们的研究结果将为前瞻性临床试验的设计提供信息(其中 可行),并促进在VHA内外传播最佳USD护理实践。
英文摘要
Background: Urinary stone disease (USD) imposes a major economic and health burden on the United States and the Veterans Health Administration (VHA). Current barriers to delivering optimal health care to patients with USD include the dearth of evidence-based process measures and treatments and the complexity of secondary prevention measures for USD. Significance/Impact: Current guidelines for best practice management of USD are largely based on clinical principles or expert opinion. The relative lack of evidence-based guidelines may lead to suboptimal care and drive unwanted practice pattern variability of quality of care for USD. The proposed research will address the following VHA/ORD priorities: Primary care practice and management of complex chronic diseases (such as recurrent USD) and quality measurement of USD prevention. Innovation: The proposed research will determine which guideline-recommended strategies are effective for secondary prevention of USD. Randomized clinical trials are not yet on the horizon, and so our findings hold the promise of rapidly expanding the evidence base for optimal care of USD and shift the clinical practice paradigm for USD towards primary care providers so that more Veterans with USD can receive effective stone prevention. Specific Aims: We propose the following specific aims: 1) Determine which prevention measures are associated with lower rates of USD recurrence in the VHA; 2) Evaluate how VHA providers are currently implementing prevention measures for USD; and 3) Identify current barriers to implementing effective prevention measures for USD in the VHA. We hypothesize the following: 1) prevention measures such as screening for primary hyperparathyroidism, 24- hour urine testing, and prescription of stone-related medications are associated with longer periods of time to recurrent USD and/or fewer stone events; 2) primary care providers are less likely than specialty providers to implement prevention measures for USD; and 3) each provider type face unique barriers that reduce utilization of effective stone prevention measures. Methodology: Aim 1 will identify a national cohort of Veterans with incident or recurrent USD between 2010 and 2016 and use methods that mimic randomized clinical trials to identify which guideline-recommended measures lead to longer times to a second USD event or fewer USD events. Aim 2 will examine the proportion of patients who receive care from primary care, nephrology, and urology providers following their index stone event and identify which providers are more or less likely to implement each prevention measure. Aim 3 will conduct national surveys with primary care, nephrology, and urology providers affiliated with the VHA to identify barriers to implementation of effective stone prevention measures. Next Steps/Implementation: The VHA is ideally positioned to support comparative effectiveness studies to determine which best practice guidelines are most effective at reducing USD recurrence. The proposed research will define more clearly best practice management of USD, evaluate how VHA providers are currently implementing prevention measures, and identify barriers that obstruct uniform adoption of best practice management of USD across the VHA. We anticipate that our findings will inform the design of prospective clinical trials (where feasible) and facilitate diffusion of best USD care practices within and beyond the VHA.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Defining Optimal Care for Urinary Stone Disease in the Veterans Health Administration
Personalized Life Expectancy to Encourage High Value Prostate Cancer Care
Personalized Life Expectancy to Encourage High Value Prostate Cancer Care
Renal Morbidity Following Kidney Cancer Surgery
  • 批准号:
    7961124
  • 项目类别:
  • 资助金额:
    $15.21万
  • 财政年份:
    2010
  • 负责人:
    John Thomas Leppert
  • 依托单位:
海外基金